Monogenic diabetes
Diabetology International · 2024-10 · 15 (4) · 679-687
DOI: 10.1007/s13340-024-00698-6 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diabetology International, online erschienen am 29.02.2024. Verfasst von Yukio Horikawa und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diabetes, Endocrinology and Metabolism, Graduate School of Medicine, Gifu University, 1-1 Yanagido, Gifu, Japan. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Diseases in which genetic factors contribute to nearly 100% of the causation by single-gene mutations are referred to as monogenic disorders or Mendelian genetic diseases. These include neonatal diabetes mellitus (NDM), presenting within the first six months of life, maturity-onset diabetes of the young (MODY), developing later in childhood or adolescence, mitochondrial diabetes (MIDD), and insulin-resistant disorders, etc. On the other hand, common lifestyle-related diseases such as type 2 diabetes (T2DM), hypertension and dyslipidemia are multifactorial, emerging through complex interplay of genetic and environmental factors. The identification of causative genes for diabetes resulting from single-gene abnormalities not only unveils previously unknown mechanisms of insulin secretion and sensitivity at the molecular level but also reveals novel targets for drug development. Moreover, monogenic diabetes in which insulin secretion is impaired serve to clarify the pathophysiology and suggest therapeutic targets for the common multifactorial type 2 diabetes mellitus prevalent in the Japanese population, which is characterized by impaired insulin secretion. In this study, we characterize the various monogenic subtypes of diabetes so far identified.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Diabetes, Endocrinology and Metabolism, Graduate School of Medicine, Gifu University, 1-1 Yanagido, Gifu, Japan.
- Clinical Genetics Center, Gifu University Hospital, Gifu, Japan.
- Center for Patient Flow Management, Gifu University Hospital, Gifu, Japan.
- Laboratory of Computational Genomics, School of Life Science, Tokyo University of Pharmacy and Life Sciences, Tokyo, 192-0392 Japan.
- Yutaka Seino Distinguished Center for Diabetes Research, Kansai Electric Power Medical Research Institute, Osaka, 553-0003 Japan.
- Center for One Medicine Innovative Translational Research, Gifu University, Gifu, 501-1194 Japan.
Zitieren
APA
Horikawa, Y., Hosomichi, K., & Yabe, D. (2024). Monogenic diabetes. Diabetology International, 15(4), 679-687. https://doi.org/10.1007/s13340-024-00698-6
Vancouver
Horikawa Y, Hosomichi K, Yabe D. Monogenic diabetes. Diabetology International. 2024;15(4):679-687. doi:10.1007/s13340-024-00698-6
BibTeX
@article{Horikawa2024,
author = {Horikawa, Yukio and Hosomichi, Kazuyoshi and Yabe, Daisuke},
title = {Monogenic diabetes},
journal = {Diabetology International},
year = {2024},
volume = {15},
number = {4},
pages = {679--687},
doi = {10.1007/s13340-024-00698-6}
}
EUVIMED